NYSE · Healthcare · Medical Instruments & Supplies · USA
Warby Parker Inc is a mid cap company (market value between $2 billion and $10 billion) in the Medical Instruments & Supplies industry.
Warby Parker is a lifestyle brand that designs and sells eyewear directly to consumers through its website and retail stores. The company offers prescription glasses, contacts, eye exams, and related services, along with technology-enabled features such as virtual try-on tools. It operates an integrated omnichannel platform combining digital commerce and physical locations across the United States.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Warby Parker Inc stock.
Overvalued: intrinsic value $17.87 per share, market price $24.99, margin of safety -39.8% (as of 2026-10-19).
A 2.1x revenue multiple, discounted for its losses, values the shares at $17.87; the price of $24.99 is 40% above that value.
Leak Score: 53/100 on 9 of 12 signals (Weak Signal).
17 more funds hold it; the full list is part of the paid plan.
All 50 Medical Instruments & Supplies stocks
6 more in this industry show a wider margin of safety.
WRBY is overvalued (as of the 2026-10-19 close). A 2.1x revenue multiple, discounted for its losses, values the shares at $17.87; the price of $24.99 is 40% above that value.
$17.87 per share (as of the 2026-10-19 close), against a market price of $24.99. That is a margin of safety of -39.8%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
53 out of 100, which we rate "Weak Signal", on 9 of 12 value investing signals.